Schweiz Med Wochenschr. 1991 Jun 29;121(26):961-9.

[Steroid therapy in multiple sclerosis].

[Article in German]

Source

Klinik für Neurologie, Abteilung für klinische Neurophysiologie, Kantonsspital St. Gallen.

Abstract

Since the 1950s steroids have been known to have a beneficial effect on recovery from acute exacerbations of multiple sclerosis. The main effect is a more rapid improvement after acute relapses due to resolution of edema in the central nervous system. Long-term steroid therapy showed no benefit in patients with a progressive course and involves dangerous side effects (Cushing's habitus, hyperglycemia, increased susceptibility to infections, peptic ulcers, osteoporosis, cataract). Intrathecal steroid administration offered no advantage over the conventional i.v. route. On the basis of a multicentre trial, ACTH therapy became the standard regime in the treatment of acute exacerbations. Recent reports have demonstrated a beneficial effect of therapy with high-dose methylprednisolone. Taking into account the restrictions and possible side effects, this therapy is a safe and efficient alternative to the standard ACTH regimen in the treatment of acute exacerbations in multiple sclerosis.

PMID:: 1650496; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Multiple Sclerosis - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Review Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. [Cochrane Database Syst Rev. 2000]
Review Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L. Cochrane Database Syst Rev. 2000; (4):CD001331.
A critique of steroid trials in multiple sclerosis. [Neuroepidemiology. 1987]
A critique of steroid trials in multiple sclerosis.
Perkin GD. Neuroepidemiology. 1987; 6(1-2):40-5.
Review Steroid therapy in multiple sclerosis. Point of view. [Arch Neurol. 1987]
Review Steroid therapy in multiple sclerosis. Point of view.
Troiano R, Cook SD, Dowling PC. Arch Neurol. 1987 Aug; 44(8):803-7.
Review [Therapeutic indications for acute episodes of multiple sclerosis]. [Rev Neurol (Paris). 2001]
Review [Therapeutic indications for acute episodes of multiple sclerosis].
Brochet B. Rev Neurol (Paris). 2001 Sep; 157(8-9 Pt 2):988-95.
Intravenous methylprednisolone for multiple sclerosis in relapse. [J Neurol Neurosurg Psychiatry....]
Intravenous methylprednisolone for multiple sclerosis in relapse.
Barnes MP, Bateman DE, Cleland PG, Dick DJ, Walls TJ, Newman PK, Saunders M, Tilley PJ. J Neurol Neurosurg Psychiatry. 1985 Feb; 48(2):157-9.

See reviews... See all...

Cited by 1 PubMed Central article

Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. [J Neurol Neurosurg Psychiatry....]
Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.
Chinchilla D, Dulac O, Robain O, Plouin P, Ponsot G, Pinel JF, Graber D. J Neurol Neurosurg Psychiatry. 1994 Nov; 57(11):1325-33.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

[Steroid therapy in multiple sclerosis].
[Steroid therapy in multiple sclerosis].
Schweiz Med Wochenschr. 1991 Jun 29 ;121(26):961-9.

PubMed
Neural signatures of economic preferences for risk and ambiguity.
Neural signatures of economic preferences for risk and ambiguity.
Neuron. 2006 Mar 2 ;49(5):765-75.

PubMed
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: hi...
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar ;101(3):299-303.

PubMed
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: p...
Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar ;101(3):e45-50. Epub 2006 Jan 10 .

PubMed
Failure of cerebrospinal fluid shunts: part II: overdrainage, loculation, and ab...
Failure of cerebrospinal fluid shunts: part II: overdrainage, loculation, and abdominal complications.
Pediatr Neurol. 2006 Mar ;34(3):171-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: